Drug intelligence / Profile preview

EMSER Hals- und Rachenspray

Development stage: Unknown
Lead developer: Siemens
Administration: Topical

Overview

EMSER Hals- und Rachenspray is a locally applied medical device (Medizinprodukt) containing Natural Emser Salt (Natürliches Emser Salz) as its sole active ingredient. Developed by Uriach Germany GmbH, it is indicated for the treatment of sore throat, hoarseness, cough irritation, and mucosal dryness. The spray works through a physical and mechanical mechanism of action, moistening the throat and pharyngeal mucosa, loosening mucus deposits, and buffering acid stress (e.g., from gastric reflux). It is free from preservatives, essential oils, and local anesthetics, making it suitable for use in children, pregnant women, and nursing mothers.

Brand names: EmserEMSER Hals- und Rachenspray
Other names: Emser Hals- und RachensprayEmser Throat and Pharynx Spray

Beyond the preview

Go deeper on EMSER Hals- und Rachenspray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EMSER Hals- und Rachenspray.

Explore the full profile